Statutory requirements for infant
formula under the Federal Food, Drug, and Cosmetic Act (the act)
are intended to protect the health of infants and include a number
of reporting and recordkeeping requirements. Among other things,
section 412 of the act (21 U.S.C. 350a), which was added by the
Infant Formula Act of 1980 (IFA), requires manufacturers of infant
formula to establish and adhere to quality control procedures,
notify FDA when a batch of infant formula that has left the
manufacturers' control may be adulterated or misbranded, and keep
records of distribution. FDA has issued regulations to implement
the act's requirements for infant formula in 21 CFR part 106 and
part 107 (21 CFR parts 106 and 107). FDA also regulates the
labeling of infant formula under the authority of section 403 of
the act (21 U.S.C. 343). Under the labeling regulations for infant
formula in part 107, the label of an infant formula must include
nutrient information and directions for use. The purpose of these
labeling requirements is to ensure that consumers have the
information they need to prepare and use infant formula
appropriately.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.